Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01017237
Other study ID # 08-2157
Secondary ID
Status Terminated
Phase Phase 4
First received August 14, 2009
Last updated May 7, 2013
Start date July 2009
Est. completion date December 2011

Study information

Verified date April 2012
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Intravenous sedation is used frequently for the relief of pain and anxiety associated with oral surgical procedures performed under local anesthesia. The purpose of this study is to learn about patient and surgeon satisfaction with sedation using Dexmedetomidine in combination with midazolam alone or with midazolam plus low dose ketamine while having wisdom teeth removed.

The sedation produced by dexmedetomidine is unique in that it mimics natural sleep, a unique quality not shared by other drugs. Dexmedetomidine is often used in anesthesia in hospital operating rooms and has been approved by the US Food and Drug Administration for the use planned in this study.


Description:

Subjects who have been screened medically and are scheduled for third molar surgery in the University of North Carolina (UNC)Oral and Maxillofacial Surgery (OMFS) clinic will be asked to volunteer for the study by the evaluating OMFS resident or attending physician. No additional x-rays will be taken other than those usually indicated for 3rd molar surgery. Informed consent will be obtained by study investigators.

Subjects will be instructed to fast for at least 8 hours prior to their appointment. Surgery will be performed in the Oral & Maxillofacial Surgery operating/sedation clinic where all monitoring equipment as well as emergency equipment is readily available, including the ability to ventilate the patient with oxygen (bag-mask), the ability to intubate, resuscitation drugs and equipment including a defibrillator. Patients will be positioned in a semi-reclining position in the dental chair and all monitors applied. A 20 gauge i.v. catheter will be placed and normal saline infusion attached. Supplemental oxygen will be administered via nasal cannula at 3 liters per minute. A picture will then be shown for recall testing. Pulse rate, arterial oxygen saturation (SpO2), respiratory rate, blood pressure, end-tidal CO2 (ETCO2), Ramsey Sedation Score (RSS sedation score) and Bispectral Index Scale (BIS) value will be recorded as a baseline and at 5 minute intervals during the procedure. Any SpO2 values below 90% as well as any episodes of apnea greater than 20 seconds will be recorded. Monitoring and recording of all data will be done by one of the investigators. Data will be recorded on pre-printed data forms. The surgical procedure will be performed by an oral and maxillofacial surgery resident physician.

Following the administration of 0.12 mg/kg of dexamethasone , dexmedetomidine will be infused at a rate of 6 mcg/kg/hr for four minutes; resulting in a loading dose of 0.4 mcg/kg. All of the above parameters will again be obtained and recorded. Patients will be randomly assigned by block randomization to receive either midazolam 0.04 mg/kg i.v. (50 patients), or midazolam 0.04 mg/kg plus 0.25 mg/kg of ketamine (50 patients). The operating surgeon and the patient will be blinded as to which protocol is being used. A dexmedetomidine infusion of 0.5 mcg/kg/hr will be initiated and continued until the completion of surgery. At this point local anesthesia will be administered in all four quadrants. Pain reaction during injections will be recorded. When efficacy of local anesthesia has been confirmed, surgery will commence. The surgery will be interrupted at 15 and 30 minutes to show a picture for recall testing by an investigator. If at any point the patient is deemed to be uncomfortable or uncooperative due to inadequate sedation, the protocol will be broken and additional sedation administered as per usual standards. The rescue therapy may include additional midazolam, ketamine, narcotic or propofol at the discretion of the anesthetist/sedationist. At the conclusion of surgery the dexmedetomidine infusion will be discontinued and the patient will be attended by a recovery nurse for collection of postoperative data. During recovery the physiologic parameters will be recorded at 10 minute intervals. When the patient achieves a recovery Aldrete score of >9, they will be asked by an investigator to recall pictures for amnesia assessment, and asked to assess patient satisfaction before leaving with an escort. The patient will be contacted on the day following surgery by phone or e-mail by one of the investigators to test for recall of pictures shown (amnesia testing) and patient satisfaction


Recruitment information / eligibility

Status Terminated
Enrollment 18
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiology (ASA) physical status I and II

- Four asymptomatic third molars indicated for removal

Exclusion Criteria:

- Clinical history or ECG evidence of:

- cardiac dysrhythmia or heart block

- ischemic heart disease

- asthma

- sleep apnea

- impaired liver, renal, or mental function

- chronic sedative or analgesic use

- allergies to any of the study drugs

- history of pericoronal infection with third molars

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Dexmedetomidine
Dexmedetomidine will be infused at a rate of 6 mcg/kg/hr for four minutes; resulting in a loading dose of 0.4 mcg/kg, Followed by an infusion of 0.5 mcg/kg/hr will be initiated and continued until the completion of surgery.
Midazolam
Midazolam 0.04 mg/kg i.v. administered after dexmedetomidine loading dose.
Ketamine
Ketamine 0.25 mg/ml administered i.v. following the dexmedetomidine loading dose and the midazolam.

Locations

Country Name City State
United States University of North Carolina School of Dentistry Chapel Hill North Carolina

Sponsors (1)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amnesia: Lack of Picture Recall Shown Prior to Sedation. Subjects were shown pictures of familiar objects prior to sedation, after the bolus dose of dexmedetomidine was administered, at 15 minutes and 30 minutes into the surgery and at the end of surgery. Subjects were shown a page containing multiple pictures to evaluate whether they could remember any of them. No recall demonstrating the presence of amnesia during that portion of the procedure. This process was repeated the day following surgery Day of surgery prior to discharge No
Primary Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown Prior to Sedation. Lack of recall of picture shown indicates presence of amnesia the day following surgery. One day after surgery No
Primary Amnesia: Lack of Picture Recall Following Dexmedetomidine Infusion Plus Midazolam. Percentage of patients unable to recall picture Day of Surgery prior to discharge No
Primary Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown Following Dexmedetomidine Infusion Plus Midazolam. Inability to recall picture shown at this time indicates presence of amnesia on the day following surgery. One day after surgery No
Primary Amnesia: Lack of Picture Recall Shown 15 Minutes Into Surgery Lack of recall of picture shown at this time indicates presence of amnesia Day of Surgery prior to discharge No
Primary Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown 15 Minutes Into Surgery. Lack of recall of picture demonstrates presence of amnesia on day following surgery One day after surgery No
Primary Amnesia: Lack of Picture Recall Shown 30 Minutes Into Surgery Lack of recall of picture shown indicates presence of amnesia Day of Surgery prior to discharge No
Primary Primary Title: Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown 30 Minutes Into Surgery. Lack of recall of picture shown indicates presence of amnesia on day following surgery. One day after surgery No
Primary Amnesia: Lack of Picture Recall at Surgery End Time. Lack of recall of picture shown indicates presence of amnesia Day of surgery prior to discharge No
Primary Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown at Surgery End Time. Lack of recall of picture shown indicates presence of amnesia on day following surgery. One day after surgery No
Secondary Respiratory Parameters: Respiratory Rate Respirations per minute Immediately prior to sedation Yes
Secondary Respiratory Parameters: Respiratory Rate Rate of respirations During surgical procedure Yes
Secondary Respiratory Parameters: Oxyhemoglobin Saturation Oxyhemoglobin saturation per pule oximeter Immediately prior to surgery Yes
Secondary Respiratory Parameters: Oxyhemoglobin Saturation Oxyhemoglobin saturation per pulse oximetry During surgical procedure Yes
Secondary Respiratory Parameters: End-tidal Carbon Dioxide Measured via capnography at nares Immediately prior to sedation Yes
Secondary Respiratory Parameters: End-tidal Carbon Dioxide Measured by capnography at nares Duration of surgery Yes
Secondary Mean Arterial Blood Pressure Blood pressure per automated monitor Immediately prior to surgery Yes
Secondary Mean Arterial Blood Pressure Measured using automated blood pressure monitor During duration of surgery Yes
Secondary Heart Rate Heart rate per EKG monitor Prior to sedation Yes
Secondary Heart Rate Per EKG monitor Duration of surgery Yes
Secondary Surgeon Satisfaction With Sedation Technique Numerical value on scale of 1-5 from Very dissatisfied (1) to Extremely satisfied (5) After surgery completed: day of surgery, within 15 minutes No
Secondary Patient Satisfaction With Sedation Technique Rating of how satisfied the patient was with their sedation on a scale of 1-5 with 1 being very dissatisfied and 5 being extremely satisfied after completion of surgery (within 15 minutes) No
Secondary Ramsey Sedation Scale Score Rating of depth of sedation by sedationist. Scale 1 - 6, 1 being widw awake and 6 being non-responsive During surgical procedure No
Secondary Bispectral Index Score (BIS) Bispectral Index (BIS) measures level of consciousness by algorithmic analysis of the patient's electroencephalogram (EEG) during anesthesia and sedation. The BIS can range from 0 (equivalent to EEG silence) to 100 (equivalent to fully awake and alert). A BIS value of 40-60 indicates an adequate general anesthesia state. During surgery duration. No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Recruiting NCT05259787 - EP Intravenous Anesthesia in Hysteroscopy Phase 4
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas